Cargando…

Response to ‘Comment on: ‘A new era for giant cell arteritis’’

Detalles Bibliográficos
Autores principales:	Mollan, S. P., Quick, V., Sinclair, A. J., Luqmani, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608276/ https://www.ncbi.nlm.nih.gov/pubmed/31767962 http://dx.doi.org/10.1038/s41433-019-0703-9

Ejemplares similares

Comment on: ‘A new era for giant cell arteritis’
por: Ing, Edsel
Publicado: (2019)

European Headache Federation recommendations for neurologists managing giant cell arteritis
por: Mollan, S. P., et al.
Publicado: (2020)

Comment on: ‘Giant cell arteritis in patients of Indian subcontinental descent in the UK’
por: Vassallo, James, et al.
Publicado: (2019)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Giant cell arteritis: reviewing the advancing diagnostics and management
por: Bilton, Edward J., et al.
Publicado: (2023)

Updates on the diagnosis and monitoring of giant cell arteritis
por: Monti, Sara, et al.
Publicado: (2023)

Profile of tocilizumab and its potential in the treatment of giant cell arteritis
por: Mollan, Susan Patricia, et al.
Publicado: (2018)

Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022)

Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis
por: Al-Mousawi, Alia Z., et al.
Publicado: (2019)

Giant cell arteritis complicated by acute pancreatitis: a case report
por: Seneviratne, Deepthi Renuka, et al.
Publicado: (2008)

Bilateral Arteritic Anterior Ischemic Optic Neuropathy Associated with Giant Cell Arteritis in Korea
por: Yoon, Hyeon-Jeong, et al.
Publicado: (2017)

Arteritic Anterior Ischemic Optic Neuropathy Associated with Giant Cell Arteritis in an Elderly Korean Man
por: Kang, Yeon-Soo, et al.
Publicado: (2016)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Mazumder, Rifat, et al.
Publicado: (2021)

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?
por: Goodfellow, Nicola, et al.
Publicado: (2017)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis. Reply
por: Karabayas, Maira
Publicado: (2021)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Response to comment on: Diagnostic positron emission tomography-computed tomography in clinically elusive giant cell arteritis
por: Mohamed, Ryian
Publicado: (2018)

ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies
por: Wang, Lihui, et al.
Publicado: (2020)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss
por: van der Geest, Kornelis S. M., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia
por: van der Geest, Kornelis S M, et al.
Publicado: (2020)

Response to comment on “New therapeutic agents in diabetic nephropathy”
por: Kim, Yaeni, et al.
Publicado: (2017)

Comment on: Diagnostic positron emission tomography–computed tomography in clinically elusive giant cell arteritis
por: Gupta, Sonali, et al.
Publicado: (2018)

SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150
por: Cadiou, Simon, et al.
Publicado: (2022)

Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective
por: Mackie, Sarah L, et al.
Publicado: (2021)

Comment on redefining authorship in the era of artificial intelligence: balancing ethics, transparency, and progress
por: Scimeca, Manuel, et al.
Publicado: (2023)

Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022)

Temporal swelling: beyond giant cell arteritis
por: Martins-Martinho, Joana, et al.
Publicado: (2023)

Identification of Herpes Zoster–Associated Temporal Arteritis Among Cases of Giant Cell Arteritis
por: BUCKINGHAM, ERIN M., et al.
Publicado: (2017)

Tozinameran: New-onset giant cell arteritis: case report
Publicado: (2022)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Giant Cell Arteritis and Cardiac Comorbidity
por: Arias, Magela, et al.
Publicado: (2021)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Treatment of Giant Cell Arteritis (GCA)
por: Régent, Alexis, et al.
Publicado: (2022)

An Unusual Case of Giant Cell Arteritis
por: Goyal, Nitasha, et al.
Publicado: (2022)

Evolution of ultrasound in giant cell arteritis
por: Kirby, Colm, et al.
Publicado: (2022)

Cardiovascular lesions in giant cell arteritis
por: Dzhus, Marta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i6uapfatmd35cgnv2b7q6gfnr8